Cotinga Pharmaceuticals Inc COTQF

Healthcare Biotechnology

Cotinga Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's lead clinical candidate, COTI-2, is an oral small molecule targeting p53, a tumor suppressor gene that is mutated in over 50% of all cancers, and the company's second clinical candidate, COTI-219, is a novel oral small molecule compound targeting the mutant forms of KRAS with such mutations occurring in up to 30% of all cancers.

GREY:COTQF - Post by User

Cotinga Pharmaceuticals Inc

<< Previous

Bullboard Posts

Next >>

Post by DIYGuyon Jul 14, 2017 12:26pm

153 Views

Post# 26469637

Stupid

I know it is was stupid but I didn't want to stare at those shares on the bid, so I bought the shares at $1.60 and $1.75. I know it is temporary but who cares. Stop giving away shares and wait for the news which eventually has to come. At this point I don't even think we will get a bounce when they determine the MTD. Hope I am wrong.

<< Previous

Bullboard Posts

Next >>

These cold weather stocks are looking to heat up for winter